Overcoming immunotherapy resistance in gastric cancer: insights into mechanisms and emerging strategies
Abstract Gastric cancer (GC) remains a leading cause of cancer-related mortality worldwide, with limited treatment options in advanced stages. Immunotherapy, particularly immune checkpoint inhibitors (ICIs) targeting PD1/PD-L1, has emerged as a promising therapeutic approach. However, a significant...
Saved in:
Main Authors: | Dingtian Luo, Jing Zhou, Shuiliang Ruan, Binzhong Zhang, Huali Zhu, Yangming Que, Shijie Ying, Xiaowen Li, Yuanmin Hu, Zhengwei Song |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-02-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-025-07385-7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advancements in cellular immunotherapy: overcoming resistance in lung and colorectal cancer
by: Lijuan Qin, et al.
Published: (2025-02-01) -
Immunotherapy with CAR-Modified T Cells: Toxicities and Overcoming Strategies
by: Shangjun Sun, et al.
Published: (2018-01-01) -
Emerging insights into intravital imaging, unraveling its role in cancer immunotherapy
by: Minfeng Yang, et al.
Published: (2025-02-01) -
Hypoxia-Induced Reactive Oxygen Species: Their Role in Cancer Resistance and Emerging Therapies to Overcome It
by: Eleicy Nathaly Mendoza, et al.
Published: (2025-01-01) -
Discussion on the mechanism of HER2 resistance in esophagogastric junction and gastric cancer in the era of immunotherapy
by: Yan Zhang, et al.
Published: (2025-12-01)